DE69732784D1 - Inhibierung von invasiver remodulierung - Google Patents

Inhibierung von invasiver remodulierung

Info

Publication number
DE69732784D1
DE69732784D1 DE69732784T DE69732784T DE69732784D1 DE 69732784 D1 DE69732784 D1 DE 69732784D1 DE 69732784 T DE69732784 T DE 69732784T DE 69732784 T DE69732784 T DE 69732784T DE 69732784 D1 DE69732784 D1 DE 69732784D1
Authority
DE
Germany
Prior art keywords
inhibitor
invasive
novel
inhibition
plasmin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69732784T
Other languages
English (en)
Other versions
DE69732784T2 (de
Inventor
Leif Roege Lund
Keld Danoe
Ross Stephens
Nils Bruenner
Helene Solberg
Claus Holst-Hansen
John Roemer Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FONDEN TIL FREMME AF ECSPERIME
Original Assignee
FONDEN TIL FREMME AF ECSPERIME
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FONDEN TIL FREMME AF ECSPERIME filed Critical FONDEN TIL FREMME AF ECSPERIME
Application granted granted Critical
Publication of DE69732784D1 publication Critical patent/DE69732784D1/de
Publication of DE69732784T2 publication Critical patent/DE69732784T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
DE69732784T 1996-12-06 1997-12-08 Inhibierung von invasiver remodulierung Expired - Lifetime DE69732784T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK140296 1996-12-06
DK140296 1996-12-06
PCT/DK1997/000555 WO1998024474A1 (en) 1996-12-06 1997-12-08 Inhibition of invasive remodelling

Publications (2)

Publication Number Publication Date
DE69732784D1 true DE69732784D1 (de) 2005-04-21
DE69732784T2 DE69732784T2 (de) 2006-04-06

Family

ID=8104458

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69732784T Expired - Lifetime DE69732784T2 (de) 1996-12-06 1997-12-08 Inhibierung von invasiver remodulierung

Country Status (6)

Country Link
EP (1) EP0942746B1 (de)
AT (1) ATE290878T1 (de)
AU (1) AU5187698A (de)
DE (1) DE69732784T2 (de)
ES (1) ES2239787T3 (de)
WO (1) WO1998024474A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810464D0 (en) * 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives
EP1406652A2 (de) * 2001-07-10 2004-04-14 Omnio AB Neue arzneimittelziele für arthritis
US6906036B2 (en) * 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US20030195164A1 (en) * 2002-04-16 2003-10-16 Veli-Matti Kahari Novel ribozyme and its use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2188322A (en) * 1986-03-26 1987-09-30 Bayer Ag Aprotinin and analogues thereof produced by a recombinant host
DE4115453A1 (de) * 1991-05-11 1992-11-12 Knoll Ag Neue wirkstoffkombination
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors

Also Published As

Publication number Publication date
EP0942746B1 (de) 2005-03-16
WO1998024474A1 (en) 1998-06-11
ATE290878T1 (de) 2005-04-15
ES2239787T3 (es) 2005-10-01
DE69732784T2 (de) 2006-04-06
EP0942746A1 (de) 1999-09-22
AU5187698A (en) 1998-06-29

Similar Documents

Publication Publication Date Title
ATE357272T1 (de) Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
MY121222A (en) Prodrugs of thrombin inhibitors
DK1261368T3 (da) Tværbunden, ikke-fungal lipaseholdig sammensætning og fremgangsmåder til anvendelse deraf
NZ335981A (en) Ketobenzamides as calpain inhibitors
DE60120151D1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
DK39093D0 (da) Enzym
DK0850307T3 (da) Alkalifile og termofile mikroorganismer og enzymer, der opnås derfra
MXPA03001268A (es) Ariloxipiperidinas sin imidazol.
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
HK1016495A1 (en) Phosphorous-containing cysteine and serine protease inhibitors
HK1029936A1 (en) Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors
HK1025511A1 (en) Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
EP0930067A3 (de) Mmp inhibitoren zur behandlung von okularer angiogenesis
AU2001275346A1 (en) Compositions, kits, and methods for identification and modulation of type i diabetes
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
ATE290878T1 (de) Inhibierung von invasiver remodulierung
IL152906A0 (en) Method for selecting enzyme inhibitors
ZA9711468B (en) New use of comt inhibitors
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
MXPA03001986A (es) Composiciones antitromboticas.
ATE280755T1 (de) 3-oxo-1-propansulfonsäure und -sulfonate
DK1144348T3 (da) LTA4-hydrolaseinhibitorer
DK0828483T3 (da) Anvendelse af tropolonderivater som inhibitorer af enzymet inositolmonophosphatase
PT1032415E (pt) Prevencao e/ou tratamento de condicoes alergicas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition